XML 36 R16.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurements
6 Months Ended
Mar. 30, 2019
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Fair Value Measurements
Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and consider assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. GAAP prescribes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs that may be used to measure fair value:
Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities;
Level 2: inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or
Level 3: unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
Money market funds, time deposits and corporate notes/bonds are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets.
Certificates of deposit, commercial paper and certain U.S. government agency securities are classified within Level 2 of the fair value hierarchy. These instruments are valued based on quoted prices in markets that are not active or based on other observable inputs consisting of market yields, reported trades and broker/dealer quotes.
The principal market in which we execute our foreign currency contracts is the institutional market in an over-the-counter environment with a relatively high level of price transparency. The market participants usually are large financial institutions. Our foreign currency contracts’ valuation inputs are based on quoted prices and quoted pricing intervals from public data sources and do not involve management judgment. These contracts are typically classified within Level 2 of the fair value hierarchy.
The fair value of our contingent consideration arrangements is determined based on our evaluation of the probability and amount of any earn-out that will be achieved based on expected future performances by the acquired entities. These arrangements are classified within Level 3 of the fair value hierarchy.
Our significant financial assets and liabilities measured at fair value on a recurring basis as of March 30, 2019 and September 30, 2018 were as follows:
 
March 30, 2019
 
Level 1
 
Level 2
 
Level 3
 
Total
 
(in thousands)
Financial assets:
 
 
 
 
 
 
 
Cash equivalents
$
97,748

 
$

 
$

 
$
97,748

Marketable securities

 


 

 

Commercial paper

 
1,975

 

 
1,975

Corporate notes/bonds
53,439

 

 

 
53,439

U.S. government agency securities

 
1,001

 

 
1,001

Forward contracts

 
3,900

 

 
3,900

 
$
151,187

 
$
6,876

 
$

 
$
158,063

Financial liabilities:


 


 

 

Contingent consideration related to acquisitions
$

 
$

 
$

 
$

Forward contracts

 
3,014

 

 
3,014

 
$

 
$
3,014

 
$

 
$
3,014

 
September 30, 2018
 
Level 1
 
Level 2
 
Level 3
 
Total
 
(in thousands)
Financial assets:
 
 
 
 
 
 
 
Cash equivalents
$
93,058

 
$

 
$

 
$
93,058

Marketable securities

 


 

 

Certificates of deposit

 
219

 

 
219

Corporate notes/bonds
54,737

 

 

 
54,737

U.S. government agency securities

 
995

 

 
995

Forward contracts

 
2,889

 

 
2,889

 
$
147,795

 
$
4,103

 
$

 
$
151,898

Financial liabilities:


 


 

 

Contingent consideration related to acquisitions
$

 
$

 
$
1,575

 
$
1,575

Forward contracts

 
3,419

 

 
3,419

 
$

 
$
3,419

 
$
1,575

 
$
4,994


Changes in the fair value of Level 3 contingent consideration liability associated with our acquisitions were as follows:
 
Contingent Consideration
 
(in thousands)
 
Other
Balance, October 1, 2018
$
1,575

Payment of contingent consideration
(1,575
)
Balance, March 30, 2019
$


 
Contingent Consideration
 
(in thousands)
 
Kepware
 
Other
 
Total
Balance, October 1, 2017
$
8,400

 
$

 
$
8,400

Addition to contingent consideration

 
2,100

 
2,100

Payment of contingent consideration
(3,757
)
 

 
(3,757
)
Balance, March 31, 2018
$
4,643

 
$
2,100

 
$
6,743


 In the Consolidated Balance Sheet as of March 30, 2019, there is no accrued contingent consideration.  In the Consolidated Balance Sheet as of March 31, 2018, there was $5.7 million of the contingent consideration liability included in accrued expenses and other current liabilities with the remaining $1.1 million in other liabilities.
Of the $1.6 million payments in the first six months of 2019, $1.6 million represents the fair value of the liabilities recorded at the acquisition date and is included in financing activities in the Consolidated Statements of Cash Flows. Of the $3.8 million payments in the first six months of 2018, $3.2 million represents the fair value of the liabilities recorded at the acquisition date and is included in financing activities in the Consolidated Statements of Cash Flows.
Non-Marketable Equity Investments
We account for non-marketable equity investments at cost, less any impairment, plus or minus adjustments resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. We monitor non-marketable equity investments for events that could indicate that the investments are impaired, such as deterioration in the investee's financial condition and business forecasts, and lower valuations in recent or proposed financings. Changes in fair value of non-marketable equity investments are recorded in Other income (expense), net on the Consolidated Statements of Operations. The carrying value of our non-marketable equity investments is recorded in other assets on the Consolidated Balance Sheets and totaled $9.4 million and $1.7 million as of March 30, 2019 and September 30, 2018, respectively.